Johnson & Johnson Vaccine Proves to Be Effective Against Delta Variant, Elicits Neutralizing Antibody Activity

Johnson & Johnson stated its single-dose COVID-19 vaccine incited strong activity against the Delta and other highly prevalent variants. The vaccine generates a strong neutralizing antibody response that does not falter.